The Europe veterinary clinical trials market size is expected to reach USD 1,650.57 million by 2032, exhibiting a compound annual growth rate (CAGR) of 9.7% during the forecast period (2024 – 2032).
The Europe veterinary clinical trials market is a growing segment within the broader veterinary healthcare and pharmaceutical industries, focusing on evaluating the safety, efficacy, and quality of veterinary products. These include drugs, vaccines, feed additives, and other therapeutics for companion animals and livestock. With a robust regulatory framework and significant investments in research and development (R&D), Europe stands as one of the leading regions in veterinary clinical trials.
Market Growth Drivers
- Increasing Prevalence of Animal Diseases
- Rising cases of infectious diseases in livestock, such as foot-and-mouth disease and avian influenza, are driving demand for effective treatments and vaccines.
- Chronic conditions like cancer and diabetes in pets also necessitate advanced therapeutic trials.
- Robust Regulatory Environment
- The EMA enforces stringent guidelines for veterinary clinical trials, emphasizing safety, efficacy, and ethical standards.
- Harmonized regulations across EU countries streamline the approval process for new veterinary products.
- Rising Pet Ownership and Expenditure
- Europe’s growing pet population, driven by urbanization and increasing human-animal bonds, boosts demand for advanced veterinary care.
- Higher spending on pet health supports the market for companion animal trials.
Download Free Sample PDF Copy of the Report:
Key companies in the Europe veterinary clinical trials market include
- Argenta
- Boehringer Ingelheim International GmbH
- Central VetPharma Consultancy
- KLIFOVET GmbH
- knoell
- Labcorp Drug Development
- Merck & Co., Inc.
- Ondax Scientific
- Veyx-Pharma GmbH
Key Market Trends
- Personalized Medicine for Pets
- Advances in veterinary diagnostics and genomics are paving the way for personalized treatments, particularly in cancer and genetic disorders in pets.
- Increased Use of Digital Tools
- Technologies like wearable devices and telehealth platforms are being integrated into clinical trials to monitor animal health and collect real-time data.
- Expansion of Livestock Trials
- Trials targeting large-scale livestock diseases, such as bovine respiratory disease and swine fever, are increasing in response to rising demand for animal-derived food products.
𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐥 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:
The research report categorizes the market into various segments and sub-segments. The primary segments covered in the study include type, application, end use and region. The splitting of the market into various groups enables businesses to understand market preferences and trends better. Also, stakeholders can develop products/services that align with the diverse needs of consumers in the industry. Besides, the research study includes a thorough examination of all the major sub-segments in the market.
Europe Veterinary Clinical Trials Animal Type Outlook
- Livestock Animal
- Companion Animal
- Other Animals
Europe Veterinary Clinical Trials Intervention Outlook
- Medicines
- Medical Device
- Others
Europe Veterinary Clinical Trials Indication Outlook
- Orthopedics
- Oncology
- Cardiology
- Ophthalmology
- Neurology
- Dermatology
- Internal Medicine
- Other Indication
Europe Veterinary Clinical Trials End User Outlook
- Academics And Research Centers
- Pharmaceutical And Biopharmaceutical Companies
- Others
Veterinary Clinical Trials Industry Developments
October 2023: Coalition for Epidemic Preparedness Innovations (CEPI) extended its collaboration with WBVR (Wageningen Bioveterinary Research) to advance WBVR’s vaccine candidate against RVF via a multi-site Phase I/IIa clinical trial.
September 2021: Argenta acquired Klifovet, a major Contract Research Organization (CRO) and Regulatory Affairs consultancy in Europe. This merger will create a global, full-value strategic partner that fosters innovation and supports large and small animal health and nutrition companies.
February 2021: The Royal Veterinary College (RVC), in collaboration with The Kennel Club, identified dental disease, obesity, and ear infections as the most common health problems in dogs. These findings will encourage pet owners to develop early habits in caring for their dogs’ teeth, ears, and body weight, promoting happier and healthier lives for their pets.
The Europe veterinary clinical trials market is poised for steady growth, driven by increasing demand for innovative animal healthcare solutions, robust regulatory frameworks, and technological advancements. While challenges like high costs and ethical considerations persist, opportunities in personalized medicine, livestock productivity, and zoonotic disease prevention offer significant potential for market expansion.